Hostname: page-component-76fb5796d-5g6vh Total loading time: 0 Render date: 2024-04-26T22:03:34.814Z Has data issue: false hasContentIssue false
  • English
  • Français

Chronic total occlusion by stent fracture in Kawasaki disease: is recanalisation possible?

Published online by Cambridge University Press:  26 July 2011

Gi-Beom Kim ,
Hyo-Soo Kim  and
Jung-Yun Choi
Gi-Beom Kim
Affiliation:
Department of Pediatrics, Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea
Hyo-Soo Kim
Affiliation:
Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea
Jung-Yun Choi*
Affiliation:
Department of Pediatrics, Seoul National University Bundang Hospital, Gyeonggi-do, South Korea
*
Correspondence to: Dr J.-Y. Choi, MD, PhD, Department of Pediatrics, Seoul National University Bundang Hospital, 300 Gumi-dong, Seongnam City, Gyeonggi-do 463-707, South Korea. Tel: +82 31 787 7281; Fax: +82 31 787 4054; E-mail: choi3628@snu.ac.kr
Get access Rights & Permissions [Opens in a new window]

Abstract

Despite various medications for Kawasaki disease, a small number of children have been undergoing interventions for severe coronary artery complications. Transcatheter intervention is a feasible alternative to coronary artery bypass grafting in a patient with chronic totally occluded lesion after Kawasaki disease, even by stent fracture.

Keywords

Coronary aneurysmpercutaneous coronary interventionpaediatric interventions
Type
Brief Reports
Information
Cardiology in the Young , Volume 22 , Issue 2 , 02 March 2012 , pp. 232 - 234
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Newburger, JW, Takahashi, M, Gerber, MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110: 2747–2771.CrossRefGoogle Scholar
2.Kato, H, Sugimura, T, Akagi, T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996; 94: 1379–1385.CrossRefGoogle ScholarPubMed
3.Terai, M, Shulman, ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 1997; 131: 888–893.CrossRefGoogle ScholarPubMed
4.Hijazi, ZM, Smith, JJ, Fulton, DR. Stent implantation for coronary artery stenosis after Kawasaki disease. J Invasive Cardiol 1997; 9: 534–536.Google ScholarPubMed
5.Akagi, T. Interventions in Kawasaki disease. Pediatr Cardiol 2005; 26: 206–212.CrossRefGoogle ScholarPubMed
6.Lee, MS, Jurewitz, D, Aragon, J, Forrester, J, Makkar, RR, Kar, S. Stent fracture associated with drug-eluting stents: clinical characteristics and implications. Catheter Cardiovasc Interv 2007; 69: 387–394.CrossRefGoogle ScholarPubMed
7.Tsuda, E, Kitamura, S. National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation 2004; 110: II61–II66.CrossRefGoogle ScholarPubMed